Medicine & Life Sciences
Crimean Hemorrhagic Fever
100%
Human Influenza
58%
Vaccination
52%
Vaccines
48%
Crimean-Congo hemorrhagic fever virus
47%
Influenza Vaccines
40%
SARS Virus
37%
Iran
31%
Synthetic Vaccines
29%
Safety
24%
Recombinant Proteins
23%
Antibody Formation
17%
Western Equine Encephalomyelitis
14%
Placebos
14%
Gastrointestinal Tuberculosis
14%
Immunization
14%
Western Asia
13%
Eastern equine encephalitis virus
13%
Cardiovascular Diseases
13%
Paecilomyces
13%
Meta-Analysis
13%
Clinical Trials
13%
Infections
12%
Angola
12%
Grape Seed Extract
12%
Ribavirin
12%
Filoviridae
12%
Far East
12%
Ticks
12%
Epidemiology
11%
Pulmonary Sarcoidosis
11%
Manuscripts
11%
Inactivated Vaccines
10%
Antigens
10%
Active Immunotherapy
10%
Brucella
10%
Voriconazole
10%
Cecum
9%
Antibodies
9%
Idiopathic Thrombocytopenic Purpura
9%
Injections
9%
Investigational Drugs
9%
Dengue
9%
Macaca
8%
Azathioprine
8%
Multicenter Studies
8%
Endocarditis
8%
Hyperlipidemias
8%
oxidized low density lipoprotein
8%
Agriculture & Biology
Crimean-Congo hemorrhagic fever
39%
Crimean-Congo hemorrhagic fever orthonairovirus
27%
influenza
17%
influenza vaccines
16%
Iran
14%
Eastern equine encephalitis virus
12%
coronary artery disease
11%
Purpureocillium lilacinum
11%
vaccines
11%
tumor necrosis factors
10%
vaccination
10%
emerging diseases
10%
dengue
9%
immunogenicity
9%
antibody formation
8%
immunization
8%
epidemiology
8%
health care workers
7%
apoptosis
7%
hands
6%
airborne transmission
6%
disseminated intravascular coagulation
6%
antibodies
5%
infection
5%